Risk of basal cell carcinoma after Hodgkin's disease [PDF]
Background: Basal cell cancer is a common skin cancer, yet studies of second tumors after Hodgkin's disease tend to exclude basal cell cancers as second malignant tumors from analysis.
Aydemir, Ü. +5 more
core +1 more source
Cutis verticis gyrata in a patient with multiple basal cell carcinomas; case presentation and review of the literature [PDF]
Cutis verticis gyrata is a rare disease characterized by convoluted folds and deep furrows of the scalp, resembling the gyri and sulci of the cerebral cortex.
Benea, Vasile +6 more
core +4 more sources
Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review
Basal cell carcinoma (BCC) is the most common skin cancer, with a lifetime risk currently approaching up to 40% in Caucasians. Among these, some clinical and pathological BCC variants pose a higher risk due to their more aggressive biological behavior ...
Santina Conte +3 more
doaj +1 more source
HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis [PDF]
Penile verrucous carcinoma is a rare disease and little is known of its aetiology or pathogenesis. In this study we examined cell-cycle proteins expression and correlation with human papillomavirus infection in a series of 15 pure penile verrucous ...
A Ouban +58 more
core +1 more source
Metastasizing basal cell carcinoma [PDF]
Abstract Basal cell carcinoma may metastasize on rare occasions. Two such cases are reported and the literature is reviewed.
B S, Mantell, J, Almeyda
openaire +3 more sources
Periungual basal cell carcinoma [PDF]
: Periungual basal cell carcinoma is rare and needs to be differentiated from other common diseases that affect this region. Several factors are associated with the development of this tumor, and sun damage seems to play an important role in its ...
Laura Loures Tavares +3 more
doaj +1 more source
Intravascular Basal Cell Carcinoma Hiding under a Keratoacanthoma
A 79-year-old male presented for removal of what was proven to be a keratoacanthoma. Additional tissue removed deep to the initial lesion revealed intravascular basal cell carcinoma (BCC).
Austin Dunn +2 more
doaj +1 more source
Safety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma. [PDF]
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and safety of vismodegib in these patients with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC) in the ERIVANCE BCC
Arron, Sarah +8 more
core +2 more sources
DACH1 suppresses breast cancer as a negative regulator of CD44. [PDF]
Dachshund homolog 1 (DACH1), a key cell fate determination factor, contributes to tumorigenesis, invasion, metastasis of human breast neoplasm. However, the exact molecular mechanisms for the anti-tumor roles of DACH1 in breast carcinoma are still lack ...
Kuang, Dong +6 more
core +2 more sources
Tumor site immune markers associated with risk for subsequent basal cell carcinomas. [PDF]
BackgroundBasal cell carcinoma (BCC) tumors are the most common skin cancer and are highly immunogenic.ObjectiveThe goal of this study was to assess how immune-cell related gene expression in an initial BCC tumor biopsy was related to the appearance of ...
Andridge, Rebecca +13 more
core +5 more sources

